Chemoinformaics analysis of cis-1,3-Dimethylcyclopentane
| Molecular Weight | 98.189 | nRot | 0 |
| Heavy Atom Molecular Weight | 84.077 | nRig | 5 |
| Exact Molecular Weight | 98.1096 | nRing | 1 |
| Solubility: LogS | -3.688 | nHRing | 0 |
| Solubility: LogP | 3.394 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 21.0251 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.436 |
| Synth | 2.603 |
| Natural Product Likeliness | 0.312 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.335 |
| MDCK | 0.0000259 |
| BBB | 0.969 |
| PPB | 0.83225 |
| VDSS | 1.73 |
| FU | 0.144451 |
| CYP1A2-inh | 0.884 |
| CYP1A2-sub | 0.755 |
| CYP2c19-inh | 0.223 |
| CYP2c19-sub | 0.863 |
| CYP2c9-inh | 0.185 |
| CYP2c9-sub | 0.844 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.194 |
| CL | 12.931 |
| T12 | 0.346 |
| hERG | 0.015 |
| Ames | 0.015 |
| ROA | 0.025 |
| SkinSen | 0.88 |
| Carcinogencity | 0.311 |
| EI | 0.988 |
| Respiratory | 0.618 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.957164 |